Mycotoxins are secondary metabolites produced by toxigenic fungi in crops worldwide. In (micro)organisms such as plants, fungi, bacteria, or animals they may be further metabolised and modified, but this is also true for food processing, which may lead to a wide range of masked mycotoxin forms. These often remain undetected by analytical methods and are the culprits for underestimates in risk assessments. Furthermore, once ingested, modified mycotoxins can convert back to their parent forms. This concern has raised the need for analytical methods that can detect and quantify modified mycotoxins as essential for accurate risk assessment. The promising answer is liquid chromatography-mass spectrometry. New masked mycotoxin forms are now successfully detected by iontrap, time-of-flight, or high-resolution orbitrap mass spectrometers. However, the toxicological relevance of modified mycotoxins has not been fully clarified.
Global concern about the contamination of agricultural commodities with mycotoxins, secondary fungal metabolites, has increased over the last years (1) (2) (3) . Although the total number of mycotoxins is unknown, it is estimated that there are thousands of fungal secondary metabolites, but only a few hundred have been documented as toxic at low amounts. This low-amount toxicity is what sets mycotoxins apart from other secondary metabolites, such as ethanol. Ethanol is not a mycotoxin, even though it is a secondary fungal metabolite (4) . The United Nations Food and Agriculture Organization (FAO) has estimated that about 25 % of the crops worldwide are contaminated with mycotoxins (1, 5) . Recent reports, however, indicate that the contamination of commodities (cereals and feed) is much higher: roughly 80 % (1, 5, 6) . These figures are expected to rise with the use of more sensitive detection methods and equipment, which will increase the mycotoxin database and standards.
The most important fungal genera producing mycotoxins are Aspergillus, Fusarium, Alternaria, and Penicillium (6) ( Figure 1 ) and the most relevant mycotoxins for animal and human health worldwide are aflatoxins B1 (AFT B1), B2 (AFT B2), G1 (AFT G1), G2 (AFT G2), and M1 (AFT M1), ochratoxin A (OTA), zearalenone (ZEN), deoxynivalenol (DON), T-2 and HT-2 toxins, fumonisins B1 (FB1) and B2 (FB2), and patulin. The European Union has regulated their maximum levels in certain foodstuffs in the Commission
Regulation (EC) No. 1881/2006 (8) and the Commission Recommendation 2013/165/EU (9).
Toxicity syndromes resulting from the intake of mycotoxins by humans and animals are known as mycotoxicoses (10) . In some cases, the manifested clinical symptoms of a mycotoxicosis are significantly greater than expected from food or feed contamination level. This has led to the discovery of the so-called masked mycotoxins, which, as their name implies, escape detection by conventional analytical methods, initially developed for specific mycotoxins (7, 11) .
As the term masked mycotoxins has often been used for all conjugated mycotoxins generated by or present in plants, animals, fungi, and food processing, Rychlik et al. (12) proposed a systematic four-tier hierarchy displayed in Figure 2 (11) (12) (13) . The first tier distinguishes free mycotoxins from matrix-associated mycotoxins and mycotoxins with modified basic chemical structure. The second tier further distinguishes biologically modified mycotoxins from the chemically modified ones. The third tier includes biologically modified compounds that are divided into functionalised, conjugated, and differently modified mycotoxins. Finally, the fourth tier, which consists of the biologically conjugated mycotoxins, is divided into plant, animal, and fungal conjugates (12) . This system, however, is sometimes difficult to use, since some masked forms can be synthesised by both fungi and plants (e.g. zearalenone sulphate) (14) .
The presence of modified mycotoxins in cereals had long been speculated, until Schneweis et al. (15) demonstrated modified zearalenone-14-glucoside (ZEN14Glc) (Figure 3 ) in naturally contaminated wheat. Three years later, Berthiller et al. (16) reported another mycotoxin glucoside in naturally infected cereals, deoxynivalenol-3-glucoside (DON3Glc) (Figure 3 ). Years that followed witnessed new evidence about mycotoxins masked/modified by technological processes, especially in cereal-based products. Mechanical or thermal processing was shown to induce mycotoxin reactions with macromolecules such as polysaccharides and proteins or decomposition of their modified form and the release of a free mycotoxin (17, 18) .
Recent research using advanced techniques based on mass spectrometry (MS) has detected and confirmed a number of modified mycotoxin derivatives. The most powerful technique among them is liquid chromatography coupled to orbitrap high resolution mass spectrometry (LC-HRMS), which has pointed to a whole new range of possibly masked mycotoxins (19) that have later been confirmed by triple quadrupole (QqQ) mass spectrometry analyser in real wheat (20) and human urine samples (21) . Beside these, liquid chromatography/tandem mass spectrometry (LC-MS/ MS) has confirmed the existence of theoretical molecules such as DON-glutathione conjugates in cereals, first synthesised and characterised by nuclear magnetic resonance spectroscopy (22, 23) .
Despite these discoveries, there are still no directives, regulations, or recommendations regarding modified mycotoxins (11, 24) . The European Food Safety Authority (EFSA) has emphasised the need for more occurrence data on modified mycotoxins in food and feed in order to assess exposure and the effects on human and animal health (13, 25) . In addition, the latest zearalenone (ZEN) risk assessment (26) included the modified forms of ZEN and confirmed even higher toxicity than that of the parent mycotoxin. The aim of this review is to describe the current knowledge about common modified mycotoxins, their formation, occurrence, analytical aspects, and toxicology.
FORMATION OF MODIFIED MYCOTOXINS
Biological modifications of mycotoxins through conjugation by plants or fungi as well as modifications caused by food processing can be the main contributors to food and feed contamination levels (11) . Table 1 gives an overview of the most common modified mycotoxins and their profile, including the matrices in which they usually occur.
Conjugation by plant
To protect themselves from xenobiotics such as mycotoxins, plants trigger a detoxification process (7, 11) consisting of the following three stages: transformation, solubilisation, and compartmentalisation. In the first stage, xenobiotics undergo hydrolysis, reduction or oxidation, which form reactive groups in the xenobiotic structure. This stage is typical for lipophilic compounds, which become more hydrophilic. When foreign substances, such as the hydrophilic ones, already possess reactive groups, detoxification skips the first stage and immediately starts with the second. In the second stage, xenobiotics are conjugated with endogenous molecules such as sugars, sulphates, or amino acids. Formed conjugates are more polar than the original xenobiotic molecule, which facilitates their compartmentalisation (the third stage) (11) . Glc levels were about 12 % of the parent mycotoxin. Glucoside forms of fusarenon-X (FUSX-Glc) and nivalenol (NIV-Glc) have been reported by Nakagawa et al. (28) in wheat artificially infected with Fusarium spp. They estimated that over 15 % of fusarenon-X (FUSX) and nivalenol (NIV) are converted into glucosides. NIV-Glc occurrence in wheat was also reported by the EFSA (13). Nakagawa et al. (29) also found neosolaniol-glucoside (NEO-Glc) and diacetoxyscirpenol-glucoside (DAS-Glc), glucosides derived from type A trichotecenes, in corn powder mycotoxin reference material. The existence of oligoglycosylated forms of deoxynivalenol (DON) has been reported by Zachariasova et al. (30) in beer, malt, and bread This prevents harmful interaction between conjugated xenobiotics and plant components. Even so, these conjugates persist in plants long enough to have important toxicological consequences for their consumers. It has been suggested that some plant conjugates undergo hydrolysis after ingestion, thereby releasing the unconjugated parent mycotoxins (7, 11) .
Beside the above mentioned ZEN14Glc and DON3Glc, there are several other plant conjugates identified and characterised in both artificial and natural samples. Lattanzio et al. (27) were the first to report T-2-glucoside (T-2-Glc) and HT-2-glucoside (HT-2-Glc) presence in naturally contaminated wheat and oats. T-2-Glc and HT-2- (60) samples. More highly glycosylated forms of T-2 and HT-2 were also reported in corn by Nakagawa et al. (31) . Except for the typical glucolysated mycotoxin forms, other mycotoxin glycosides can occur, formed through conjugation by sulphatase (i.e. deoxynivalenol-suflates, DON3Sulf and DON15Sulf) (20) or glutathione S-transferase (19, 22) . A glutathione DON adduct (DON-GSH), together with a range of related conjugates, has been investigated by Uhlig et al. (24) in naturally contaminated grain. The authors managed to identify glutathione (GSH), c y s t e i n y l g l y c i n e ( C y s G l y ) , c y s t e i n e ( C y s ) , γ-glutamylcysteine (γ-GluCys), and N-acetylcysteine (NAC) coupled at the 13 th position on the epoxy group in the DON molecule, which was the first report of in vivo conjugation of trichotecenes via their epoxy group, generally considered as unreactive. Since DON-GSH is likely to be nontoxic and its formation irreversible, it was suggested that the identification of cereal genotypes that utilise the GSH-conjugation pathway may be useful in the future breeding strategies aiming to decrease DON accumulation in cereals (24) . On the other hand, enhancing resistance to Fusarium spp. head blight (FHB) in wheat, often regarded as the best option to reduce fungal colonisation and mycotoxin contamination, showed to have an unexpected effect on masked mycotoxin content. According to Lemmens et al. (32) , FHB-resistant wheat lines can metabolise DON to DON3Glc and decrease both DON and DON3Glc contamination. However, increased FHB resistance together with a decrease in DON content results in a conjugate increase in the relative fraction of the masked toxin compared to the parent. Such result is explained by the fact that increasing FHB resistance makes the reduction of DON content more efficient than the reduction of DON3Glc contamination.
In addition, other mycotoxin forms can occur, such as a mixed sulphate/glucoside diconjugate of a mycotoxin first reported by Soukup et al. (33) in 2016. The conjugates were found in tomato tissues and tobacco suspension cells inoculated with Alternaria toxins [alternariol (AOH), alternariomethyether (AME), tenauzonic acid (TEA), tentoxin (TTX) and others]. Regarding the fact that they can be formed by all mycotoxins and their phase I metabolites with two or more hydroxyl groups, the authors suggested that diconjugates should be taken into account in future modified mycotoxin analyses.
Conjugation by fungi
3-acetyl-deoxynivalenol (3Ac-DON) and 15-acetyldeoxynivalenol (15Ac-DON) are well known fungal conjugates. The production of these two biosynthetic precursors of DON was studied by Alexander et al. (34) , who have elucidated the genetic basis for the difference between the 3-and 15Ac-DON chemo type. It was later found in a study with F. graminearum (11) that it is an esterase encoded by TRI8 which mediates the acetylation of trichotecene biosynthetic intermediates 3 and 15-diacetyl-DON at either the C-3 or C-15 position, and that its differential activity determines 3Ac-DON or 15Ac-DON formation. 3Ac-DON and 15Ac-DON have generally been reported to occur together with DON (25) . According to the EFSA opinion of 2013 (25) , the average contribution of 3Ac-DON to the sum of DON and its derivatives was <2 % at the lower-bound estimate and 13-20 % at the upper bound estimate, and of 15Ac-DON 10-15 % at both lower and upper bound estimates. As early as 1975, Yoshitzawa and Morooka (35) FUSX is another fungal conjugate that is a precursor in the biosynthesis of NIV. The presence of FUSX has already been proven in Fusarium infected maize, even though the concentrations and the incidence were small (11) .
Fungi also have the ability to metabolise mycotoxins produced by mycotoxigenic fungi. The case in point is zearalenone (ZEN) and the formation of zearalenone-14-sulphate (ZEN14Sulph) in the saprobic Rhizopus fungus, frequently found on plants, fruits, and vegetables (11) .
Conjugation by mammals
Conjugates formed by mammalian mycotoxin metabolism in the liver and excretion via urine are unlikely to play any important role in food (7) but are worth mentioning to get a comprehensive overview of the topic. Common mycotoxin conjugates produced by mammals are DON (36, 37) and ZEN (37-39) glucoronides and sulphates. Mammalian conjugates in urine can serve as biomarkers of exposure to certain mycotoxins. This is particularly true since a dose-response relationship has been established by Šarkanj et al. (40) Beside conjugation, mammalian metabolism can create a cleavage, such as the one of phenylalanine moiety in ochratoxin A (OTA), and produce ochratoxin alpha (OTα) (Figure 4 ). To eliminate OTA and OTα, animals resort to glucuronidation, and the new glucuronides can occur on several positions: OTA-acyl-GlcA, OTA-phenol-GlcA, and OTA-amino-GlcA. OTα is also glucuronidated and mainly excreted via urine as OTα-acyl-GlcA and OTα-phenol-GlcA (Figure 4) . The conjugated forms of OTA and OTα have been confirmed only indirectly with and without enzymatic hydrolysis of biological fluids of subjects exposed to OTA (45) .
Food processing effects
The effects of food processing on the stability of free mycotoxins have been well researched, but on modified or unregulated mycotoxins far less so. Still, we do know that food processing can significantly contribute to the formation and the final concentrations of modified mycotoxins in certain food products (11, 46) .
One such process is coffee roasting, which causes the formation of several degradation products of OTA ( Figure  4 ), such as 14R-ochratoxin A and 14-decarboxy-ochratoxin (12, 47, 48) . According to Bittner et al. (47) , further thermal reaction leads to the binding of OTA to coffee polysaccharides via esterification and production of OTA esters such as OTA-glucose ester, OTA-methyl-α-D-glucopyranoside ester, and OTA-cellobiose ester (Figure 4) .
Effects of extrusion on mycotoxins depend on time and temperature of the process, as well as on other factors. In the case of fumonisins (FBs) (Figure 5 ), the presence of additives, reducing sugars, and sodium chloride is crucial (46) . Studies indicate that the greatest reduction of FBs occurs in the presence of glucose at 160 °C or more (13, 46, 49) . In the Maillard-type reaction with reducing sugars, this loss in FB content likely reflects on the formation of degradation products N-carboxymethyl fumonisin B1 (NCM-FB1) and N-deoxyfructosyl fumonisin B1 (NDF-FB1) (50, 51) . These fumonisin derivatives have been reported in maize products by Seefelder et al. (52) , and their toxicity investigated by Hartl and Humpf (53) . In addition, the hydrolysed form of fumonisin B1 (HFB1) created by the cleavage of both carballylic moieties ( Figure 5 ) is commonly obtained upon alkali treatment (13, 50) , for example in the production of traditional tortillas in South America (46) . Due to similar chemical properties of FBs and HFBs, the reaction scheme proposed for the modification of FB1 to NCM-FB1 and NDF-FB1 can also apply for the modification of FBs and HFBs ( Figure 5 ). The occurrence of HFBs was recently investigated by Bryła et al. (54) in maize-based products, who concluded that the masked to free fumonisin concentration ratio in thermally processed food such as corn flakes and various snacks was higher than in unprocessed products such as flour or raw popcorn grains due to food processing. Voss et al. (55) have also confirmed that extrusion and nixtamalisation can reduce FB toxicity through hydrolysation. In 2017, Bryła et al. (56) investigated the effect of pH and baking temperature on the stability of FBs in a maize product and confirmed that FBs are decomposed to HFBs and partly hydrolysed FBs. Thermal processing of up to 250 °C, did not, however, degrade the FBs. The authors also detected that only 20 % of FBs were bound and that lower dough pH increased the bound FB content. Earlier, the same group of authors found FBs physically entrapped into the structure of macromolecular components such as starch during bread making (57) . These FBs were entrapped in a gluten-free bread up to 80 % of the parent form. They have also reported a smaller decrease in the content of hidden FBs compared to the free molecules, which was explained by a matrix stabilisation effect (57) . In addition, these forms of FBs formed through an associative interaction between the toxin and matrix Kovač M, et (45, 91) macroconstituents are in the literature often called "hidden", while the above mentioned FBs, covalently linked to any matrix constituents, are referred to as "bound" (58) (59) (60) . Even though the entrapping mechanism is still to be clarified from the physicochemical point of view, the existing data indicate that biopolymers such as amylose and amylopectin can form inclusion complexes with FBs. These forms can easily degrade under in vitro digestion conditions and are therefore toxicologically relevant (50) .
Figure 4 The structures of ochratoxin A, its metabolites, and processing by-products
The fate of DON and DON3Glc during bread making was studied by several other authors (30, (61) (62) (63) . Vidal et al. (61) reported that baking reduced the concentration of DON but increased that of DON3Glc. They attributed this rise to glycosidation of DON in the initial stages of baking, before enzyme inactivation. This hypothesis is supported by the fact that DON3Glc also increases during fermentation, as previously suggested by Zachariasova et al. (30) . The most recent, 2017 study by Generotti et al. (17) investigated the effects of baking on the final trichotecene (DON, DON3Glc, and Fusarium metabolite culmorin) content by modifying technological parameters and recipe ingredients. The results suggest that pH and baking time have an important role in minimising mycotoxins in the final product, while changes in the recipe can change mycotoxin extractability by affecting biscuit microstructure. Higher pH during wholegrain biscuit production reduced DON concentrations. Baking time effectively reduced DON and DON3Glc content in the final product (up to 80 %). Culmorin concentrations positively correlated with DON.
Beer production, in turn, raises great concern about possible formation and transfer of Fusarium mycotoxins from raw materials to final beer products (13, 46) . A significant increase in the level of DON3Glc was observed during malting and brewing (64, 65 ). An increase was also observed in the levels of acetylated DON forms (AC-DONs) across the beer production chain (64) . Their levels in barley were about 40 % of free DON, while in beer they were comparable or higher (64, 66) . Even though there are several theories explaining the increase in DON3Glc, there are two phenomena that should be considered. The first includes de novo growth of Fusarium spp. during malting, accompanied by the production of additional mycotoxins and their transformation products. The second phenomenon relates to the degradation of cell walls, membrane-bound proteins, and starch depots by enzymes produced during mashing of malt grits, which leads to releasing DON3Glc from insoluble forms (18, 65) .
Recently, Karlovsky et al. (67) gave an overview of how food processing and detoxification treatments relate to mycotoxin contamination. In some cases, food processing reduces mycotoxin content, such as cleaning, milling, brewing, fermentation, cooking, baking, roasting, alkaline cooking, nixtamalisation, and extrusion. However, food processing can seldom completely eliminate mycotoxins from a food product. The authors pointed out that the disappearance of parent mycotoxin does not necessarily mean detoxification because of its conversion into a "masked" form that escapes detection and has unknown toxic potential. They also allowed the possibility of cocontamination with other mycotoxin-producing fungi (63) .
OCCURRENCE
The information on mycotoxin occurrence in food and feed is crucial for the assessment of consumer exposure and for setting maximum regulatory levels for certain products. It is general perception that mycotoxin levels have been underestimated exactly because of the modified mycotoxins (48) . Over the past few years, however, the occurrence of the modified forms has been extensively researched, DON3Glc and ZEN14Glc in particular. Malachová et al. (68) monitored the occurrence of several mycotoxins in 116 cereal-based products from the Czech market. DON was found in 75 % of samples with its levels varying between 13 and 594 μg kg -1 , while the prevalence of DON3Glc was even higher (80 %) and its levels ranged between 5 and 72 μg kg -1 . The latter was found in a single whole-grain slice product (68) .
The occurrence of DON, DON3Glc, and 3Ac-DON in beer was investigated by Varga et al. (66) . ). Regarding the DON equivalents, of the total DON content, 62 % were metabolites, whereof 17 % were the glycosylated form DON3Glc. The occurrence of ZEN was 80 %, while its glycosylated and sulphated forms were detected in 40 % of the samples (69) .
Cereal-based products (fibre-enriched bread, branenriched bread, breakfast cereals, popcorn, and oatmeal) from Belgium were also analysed by De Boevre et al. (44) for the occurrence of DON, DON3Glc, AC-DONs, T-2, HT-2, and ZEN and its conjugates. All 174 samples were co-contaminated with three to eight mycotoxins, including one to three modified forms. DON was the major contaminant of wheat-based matrices. DON3Glc was found in half of the fibre-enriched bread samples and breakfast cereal samples and in 77 and 92 % of popcorn and oatmeal samples, respectively. The highest prevalence of AC-DONs was recorded in popcorn, followed by oatmeal samples, and 3Ac-DON was more frequent than 15Ac-DON. ZEN prevalence was the highest in oatmeal samples (62 %), while that of ZEN conjugates was the highest in breakfast cereal samples (roughly 30 %).
An extensive global research of animal feed contamination by mycotoxins by Kovalsky et al. (1) , that included 1113 samples (of finished feed, maize, and maize silage) collected between 2012 and 2015 from 44 countries and analysed for 57 mycotoxins and metabolites, showed that the regulated toxins, DON, ZEN, and to a certain extent FBs had the highest levels. ZEN contaminated 88 % of the investigated matrices and DON 79 %. The prevalence of the related masked forms ZEN14Sulph and DON3Glc was also high: 47 % and 70 %, respectively. The authors also established a positive correlation between DON and ZEN and their masked forms. In addition, the authors observed distinct trends of mycotoxin occurrence within a region over the years, suggesting the importance of cultivars and local weather (1) .
Even though the data on the occurrence of modified mycotoxins are coming to light all over the world, this cannot be said for Croatia. There are only a few reports of masked mycotoxin levels in Croatian cereals: 47.8 µg kg -1 for DON3Glc and 176.6 µg kg -1 for DON3Glc in wheat (40) , and 546 µg kg -1 for DON3Glc and 788 µg kg -1 for DON3Glc in maize (70) .
ANALYTICAL ASPECTS
Obviously, there are no accurate data on the occurrence of free and modified mycotoxins without reliable analytical methods. There are many chromatographic methods, mainly based on liquid chromatography (LC), and immunochemical methods, such as enzyme-linked immunosorbent assays (ELISA), that provide reliable measurement of free mycotoxins. However, the latter are still not selective enough for modified mycotoxins, as they sometimes respond to more than one compound and yield a single, fake positive, or overestimated result (7, 12, 13) . This "cross-reactivity" effect was evidenced for DON, ACDONs, and DON3Glc. The latter two can contribute to DON content overestimation in some matrices (7, 71 ). Yet, cross-reactivity can be useful in determining modified mycotoxins. For instance, commercially available immunoaffinity columns (IACs) for DON analysis are known to cross-react with its analogues DON3Glc, 15Ac-DON, and 3Ac-DON to a variable extent, which can be a valuable tool for evaluating total DON content in samples (72) .
In general, mycotoxin analysis is a complex process which requires proper sampling (strategies), sample preparation, detection, and quantification by means of suitable analytical instruments. Sample preparation implies extraction of the toxin from the matrix with suitable solvent, clean-up of the extract in order to eliminate interferences from the matrix, and sample concentration if necessary. The analysis of modified mycotoxins is even more complicated and usually involves one of the two approaches: direct or indirect (7, 12, 13) . The direct approach employs the conventional, standardised methods developed for free mycotoxin determination but adjusted and optimised to suit the properties (polarity, extraction behaviour, detection characteristics) of targeted modified mycotoxins. The major drawback of the direct approach is the lack of analytical standards necessary for the analysis of all masked or modified forms of mycotoxins. The indirect approach, in turn, is usually based on chemical and/or enzyme treatment to transform modified forms into their parent mycotoxin, which can then be determined with routine analysis. The downside is that the information it provides does not distinguish between free and modified mycotoxins. This is why direct LC-MS methods have become methods of choice when it comes to modified mycotoxin determination (12) . For over a decade, LC-MS/MS has been the golden standard for routine food safety control, as it Kovač Yet, these QqQ methods have their limitations. Firstly, the number of analytes that can be analysed in a single run is restricted by the MS/MS quality. Secondly, only targeted compounds can be detected, and quantification requires the use of analytical standards, which limits determination of most modified mycotoxins (2) . Thirdly, accurate mycotoxin quantification in different matrices requires matrix-assisted calibration or appropriate internal standard, and these standards and (certified) reference materials are still not widely available. There are several producers who now provide modified DON, T-2, HT-2, and Alternaria mycotoxins (Romer labs ® , Toronto Research Chemicals, Sigma Aldrich ® and others) to overcome this limitation. Recently, full-scan techniques have been studied as a way to complement the QqQ methods. LC coupled to high resolution mass spectrometers (HRMS) has the advantage over QqQ, as it enables target analysis, identification of new non-targeted compounds, and retrospective data analysis (2, 13) . While it may be less sensitive than QqQ, LC-HRMS orbitrap is regarded as a powerful tool for multiclass, multi-analyte analysis in food safety (76) . It has been used in a number of studies to scan for and measure modified DON, (19, 77) modified type A trichotecenes (29) , OTA polysaccharide esters (47) , or glycosyl derivatives of T-2 and HT-2 (27) .
However, HRMS still needs to resolve issues such as isobar co-elution and unknown molecule identification to become a fully effective food safety control tool. These issues have been addressed by the introduction of ion mobility spectrometry (IMS), which can provide a better insight into the formation and characterisation of novel modified mycotoxins, but requires further testing (2) . Another issue of HRMS are the levels of detection, which are much higher than with QqQ. In practical terms, fewer naturally contaminated samples can be quantified by HRMS. Furthermore, HRMS is associated with a huge number of artefacts and nonspecific peaks in real samples, so the use of C-13-labelled standards or sample pairs is necessary for positive identification of new components (19) .
In terms of mycotoxin determination in the future, multi-mycotoxin LC-MS/MS and LC-HRMS methods will continue to play an important role in screening, confirmation, and quantification of hundreds of fungal metabolites in food and feed samples and will be complemented by metabolomics in order to reveal the fundamental biological processes behind mycotoxin production and its reduction (78) .
TOXICOLOGICAL RELEVANCE
Knowledge about the toxicological relevance of modified mycotoxins is still modest (79) (80) (81) . Most of the concerns address the potential health effects of conjugated and matrix-associated mycotoxins, mainly due to indirect toxicity via hydrolysis to their free forms (11, 12, 79, 80) .
In vitro studies
By mimicking natural conditions during digestion, in vitro studies examine the fate of modified mycotoxins in contact with stomach juices and interaction with human colonic microbiota. So far, these studies have mostly focused on the derivatives of ZEN and DON (11, 12) . A 2013 study by Dall'Erta et al. (79) has been the first to demonstrate that DON and ZEN conjugates are effectively cleaved by the human colonic microbiota. In the process they release their aglycones and generate unidentified catabolites. The authors showed nearly the full recovery of DON3Glc, ZEN14Glc, and ZEN14Sulph by enzymatic treatments (99.5 %, 97.3 %, and 98.6 %, respectively). The effects of human colonic microbiota were analysed in the first 30 min and at 24 h of fermentation. The ZEN derivatives were completely cleaved after 30 min, while ZEN was only partially recovered in the faecal slurry (39 % after 30 min and 40 % after 24 h), which implied the possibility of further ZEN degradation into unknown compounds. DON3Glc was almost completely degraded after 24 h (11, 79) .
In 2016, Cirlini et al. (82) reported that ZEN14Glc and its positional isomer ZEN16Glc crossed the cell barrier and were absorbed by Caco-2 cells in a time-and concentrationdependent manner. The conjugates were cleaved to release the parent molecule, and ZEN14Glc was more prone to deglycosylation than ZEN16Glc. The authors also showed that human cytosolic b-glucosidase cleaved ZEN14Glc but not ZEN16Glc, and that ZEN14Glc and ZEN16Glc were hydrolysed inside the cell. This implies that ZEN generated in situ can be taken up by intestinal cells and metabolised into phase I and phase II metabolites, which can contribute to the overall oestrogenic load.
Pierron et al. (83) also used Caco-2 cells to assess the ability of DON3Glc to elicit a ribotoxic stress and induce intestinal toxicity. DON3Glc did not bind to the main targets of DON toxicity and therefore did not activate JNK and P38 MAPK pathways in Caco-2 cells or change their viability and barrier function. The authors concluded that glucosylation of DON suppressed its ability to bind to the ribosome and decreased its intestinal toxicity.
One in vitro digestion assay proved the stability of FB covalent conjugates (bound fumonisins) (59), while another (84) showed that FBs forming complexes with matrix macroconstituents (hidden FBs) released their free forms and became available for intestinal absorption. The static model used by Dall'Erta et al. (79) was also used to analyse modified FBs. These studies suggest that even if FB levels in products do not exceed the legal limit, digestion can increase their bioavailability through hidden FBs. This brings us back to the need to include masked mycotoxins in any serious risk assessment.
Considering that the intrinsic cytotoxicity of modified DON3Glc, 3Ac-DON, and 15Ac-DON (AC-DONs) has not been investigated as extensively as of their parent mycotoxins, Broekaert et al. (85) compared their in vitro cytotoxicity towards differentiated and proliferative porcine intestinal epithelial line derived from the jejunum (IPEC-J2). The cytotoxicity of DON and its modified forms after a 72-hour exposure was as follows: DON3Glc<<3Ac-DON<DON≈15Ac-DON. The authors, however, emphasized that cytotoxicity to IECs was only one toxicological endpoint, while other, such as the effects on the immune system, could have significantly more or less sensitive dose-response curves.
Beside in vitro studies, Dellafiora et al. (86) carried out an in silico study to gain an insight into the systemic fate of ZEN14Glc. They monitored the hydrolysis and the transformation of the masked mycotoxin in bovine blood and blood components. All matrices showed hydrolysis, and the whole blood showed ZEN isomers. Further assessment of (bio)transformation in the blood stream is needed to better understand the in vivo action of ZEN and its modified forms.
In vivo studies
The first reported study on modified mycotoxins in vivo comes from 1990, when Gereis et al. (87) noted a decomposition of ZEN14Glc in pigs and detected ZEN and its metabolites in urine and faeces. Although they evidenced the complete hydrolysis of ZEN14Glc, they found no associated clinical signs of oestrogenic activity. Two decades later, Veršilovskis et al. (88) reported unstable ZEN14Glc in rat stomach (35 % and 46 % were recovered), which rapidly hydrolysed to free ZEN. In the intestine only small amounts of ZEN14Glc were observed (0.5 % in the small intestine, 2.5 % in the colon). Both studies evidence that ZEN14Glc is rapidly hydrolysed in vivo and that its contribution to overall mycotoxin toxicity is highly probable. However, to fully understand toxicokinetics and species differences further research is needed (80, 81) . Veršilovskis et al. (88) also reported 37 % and 51 % recovery of DON3Glc in the stomach, whereas the release of DON was only 2 %. In the small and large intestine no free DON and small traces of DON3Glc were found. In another study by Nagl et al. (89) only a very small percentage of DON3Glc was found in urine after administration, while the majority was found in faeces, indicating that faecal excretion is the major route of DON3Glc elimination in rats. The authors have suggested that DON3Glc in food and feed is less toxic than DON but have also allowed that its bioavailability and metabolism are species-dependent due to differences in the anatomy and gut microbiota. Two years later the same group of authors (90) studied the possibility of DON3Glc cleavage during ingestion in pigs. After the oral dosing of DON3Glc, urinary DON was the main excretion product after 24 h, while only trace amounts of the metabolite were found in faeces. These findings indicate that DON3Glc is almost completely hydrolysed in the gastro-intestinal tract of pigs. Compared to its parent form, DON3Glc seems to be less bioavailable and therefore less relevant toxicologically. However, the authors emphasised the possibility of DON3Glc having a biological activity of its own, which deserved more attention.
CONCLUDING REMARKS
The term masked mycotoxin was initially used to highlight difficulties in the detection of certain compounds by routine analysis. To avoid misunderstanding and introduce uniform interpretation, especially in legislation, the term has been limited to cover only biologically modified mycotoxins conjugated by plants.
Mass spectrometers brought the possibility to analyse several mycotoxins at once and simplified the discovery of novel compounds. Consequently, it has become evident that modified mycotoxins co-exist with their native compounds in contaminated agricultural commodities, sometimes in the same or even higher level. This has raised the question of their toxicological relevance and adverse health effects. Toxicological studies have confirmed that certain modified mycotoxins are hydrolysed into their free forms after the ingestion. However, further research is needed to fully clarify their fate upon ingestion. Their physiological and toxicological role should also be assessed, because some of the toxins may not act as their parent compound. The outcome of these toxicological researches will hopefully drive the legislators to expand regulations to encompass both free and modified mycotoxins.
